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Objective To examine the use of hormonal contraceptives among
immigrant and native women in Norway.
Design Nationwide registry-based study based on merged data
from the Norwegian Prescription Database, the Norwegian
Population Registry, the Regular General Practitioner Database
and the Medical Birth Registry.
Setting Norway.
Sample All women born abroad to two foreign-born parents
(immigrants), or born in Norway to two Norwegian-born parents
(natives) aged 16–45 years, who lived in Norway in 2008.
Methods Data on all collected supplies of hormonal
contraceptives in 2008 were merged with demographic,
socio-economic and immigration data, information on any
delivery and women’s general practitioners.
Main outcome measures User rates of hormonal contraception
and predictors of contraceptive use.
Results A total of 893 073 women were included, of whom
130 080 were immigrants. More native women (38%) used
hormonal contraceptives compared with all immigrant groups
(15–24%). The odds ratios for any use of hormonal contraceptives
for immigrants compared with Norwegian-born women were;
Nordic countries 0.53, South and Central America 0.53, Western
countries 0.39, Asia 0.30, Eastern Europe 0.29, Africa 0.29. Work,
education, long stay in Norway and young age of immigration
predicted the use of hormonal contraceptives among immigrants.
Conclusions The use of hormonal contraceptives varies between
natives and immigrant groups. Further work is needed to
ascertain whether these differences can be explained by higher
desires for fertility, preferential use of non-hormonal
contraceptives or other reasons identified through qualitative
research.
Keywords Contraceptive agents, family planning, immigrant
women, prescription database.
Please cite this paper as: Omland G, Ruths S, Diaz E. Use of hormonal contraceptives among immigrant and native women in Norway: data from the
Norwegian Prescription Database. BJOG 2014;121:1221–1228.
Introduction
Family planning is considered an essential human right by
the United Nations Population Fund.1 Hormonal contra-
ception is an effective way of family planning1–3 but its use
differs greatly between women from different countries and
cultures.1,4,5 The increasing numbers of immigrants in Eur-
ope actualises the need for studying the use of contracep-
tion in these groups.
Immigrants, defined as persons born abroad to two for-
eign-born parents, constituted 12% of the population in
Norway by January 2013. Immigrants in Norway are a het-
erogeneous group originating from 220 different countries.6
Although immigrant women may have different needs and
traditions for use of hormonal contraceptives as compared
with the native population, patterns may change over time
with adaptation to their new country of residence. Studies
on screening for cervix cancer suggest that differences in
use of health care services between immigrants and natives
become less pronounced with increasing length of stay in a
new country.7
Induced abortions can be understood as unmet needs of
contraception. Studies from the Nordic countries and the
USA show that unintended pregnancy and induced abor-
tion occur more commonly among minority women.4,8–10
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Epidemiology
The use of contraceptives, and the level of knowledge about
contraceptive methods, appears to be lower among
immigrant than native women undergoing induced abor-
tion.10–12 A newly published study based on a health survey
studying self-reported use of contraceptives found a lower
use of contraceptives among immigrants than native
women in France.13 To our knowledge there are no prior
studies that compare contraceptive use between different
groups of immigrants and natives at the population level.
Such knowledge is essential for gynaecologists, general
practitioners (GPs), and other health professionals in order
to provide adequate guidance regarding family planning.
The aim of this study was to analyse the use of hor-
monal contraceptives in various groups of immigrants and
native women in Norway. In addition, we aimed to identify
predictors for hormonal contraceptive use in these groups.
Methods
Data sources
This cross-sectional study is based on merged data from
the Norwegian Prescription Database,14 the Norwegian
Population Registry,15 the Regular General Practitioner
Database,16 and the Medical Birth Registry Norway.17
The Norwegian Prescription Database is a national
health registry containing detailed information on all pre-
scription drugs purchased by individual people at all phar-
macies in Norway.18 The data extracted for this study
comprised all collected supplies on hormonal contracep-
tives, Anatomical Therapeutic Chemical (ATC) system code
G02BA03 (intrauterine devices [IUDs]), G02BB01 (vaginal
rings), G03A (oral, injections, patches, implants) and
G03HB01 (oral) dispensed in 2008. Oral contraceptives,
patches, rings and injections are usually prescribed in
90-day lots for at least a 12-month supply, while IUDs and
implants usually last for several years. Hormonal contra-
ception is strongly subsidised to 16–19-year- old women in
Norway. We defined all women who collected one or more
supplies of hormonal contraceptives during 2008 as contra-
ceptive users, regardless numbers of drug supplies.
The Norwegian Population Registry comprises informa-
tion on immigration, socio-economic status and demo-
graphics for all long-term residents in Norway.15 The
following variables were included in this study: (1) immi-
grant status: country of origin, length of stay in Norway,
and immigrant category according to the definitions of
Norwegian Population Registry;19,20 (2) socio-economic
variables: being in education and employment status; (3)
other demographic variables: age and marital status. For
married women, we also extracted information about their
spouses’ immigrant status.
The Regular GP Database contains information on the
population assigned to each GP in Norway.16 For the pur-
pose of this study we obtained information about the
women’s GP including GP age, gender, and immigrant
status.
The Medical Birth Registry contains information on all
births in Norway since 1967.17 A single variable from the
registry was extracted for this study; dichotomised informa-
tion on whether a woman had given birth between 1 Janu-
ary 2008 and 30 June 2009 was used to identify those
women who had been pregnant in 2008.
The variables selected from these four registries were
linked, using the unique 11-digit personal identity number
assigned to every citizen in Norway. The Norwegian Social
Science Data Service was responsible for supplying the final
anonymous data file to the researchers.
Study population
The study population was restricted to women between 16
and 45 years old. Altogether, 959 512 women aged 16–
45 years lived in Norway in 2008. Women born outside of
Norway to two foreign-born parents were defined as immi-
grants, and those born in Norway to two Norwegian-born
parents were defined as natives. All other women were
excluded. The study population comprised 893 073 women,
762 993 natives and 130 080 immigrants, and was divided
into the following seven groups based on country of origin:
(1) Norway; (2) Nordic countries except Norway; (3) East-
ern Europe; (4) Western Europe, North America, Australia
and New Zealand; (5) Africa; (6) Asia including Turkey
and Oceania except Australia and New Zealand; (7) South
and Central America. Throughout this paper, the collective
terms ‘Western countries’ will be used for group 4, and
‘Asia’ for group 6.
For the purpose of logistic regression analysis, we also
divided the study population into three groups according
to user rates of hormonal contraceptives: native women;
aggregated immigrant group with relatively high use of
contraceptives (women from Nordic countries, Western
countries, and South and Central America); aggregated
immigrant group with relatively low use of contraceptives
(Africa, Asia, and Eastern Europe).
Statistical analysis
We conducted descriptive analyses on the use of oral and
non-oral hormonal contraceptives stratified for three age
groups (16–25, 26–35, 36–45 years). Non-oral formulations
included intrauterine devices (IUDs), patches, vaginal rings,
implants and injections. Binary logistic regression analysis
was conducted, with use of some hormonal contraceptive as
dependent variable and the following independent variables:
each immigrant group according to area of origin, age,
being in work and/or education, GP gender, and Norwegian
versus immigrant GP. Because we found significant interac-
tions (P < 0.001) between area of origin and several inde-
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pendent variables, we chose to present the results as crude
ORs for the different world areas and adjusted ORs for
three aggregated groups in complementing figures. Regres-
sion analyses were also conducted separately for the three
aggregated groups including the independent variables being
in work and/or education, length of stay in Norway, age on
immigration, marital status, if women had given birth
between 1 January 2008 and 30 June 2009, Norwegian ver-
sus immigrant GP and GP gender. Length of stay in Norway
was dichotomised into over or under 5 years, based on user
rates for contraceptives (Figure 1). Associations are shown
as odds ratio (OR) with 95% confidence interval (CI).
Analysis was performed using IBM SPSS 19 (PASW Sta-
tistics for Windows; SPSS Inc, Chicago, IL, USA).
Ethics
This study is part of the project ‘Immigrants’ health in Nor-
way’, which has been approved by the Regional Committee
for Medical and Health Research Ethics and the Norwegian
Data Inspectorate. The Norwegian Directorate of Health
has given an exemption from the duty of confidentiality.
Results
The study population comprised 893 073 women aged 16–
45 years, 130 080 (14.6%) of whom were immigrants. Of
the immigrant women, 38% were born in Asia, 25% in
Eastern Europe, 12% in Africa, 11% in Nordic countries,
10% in Western countries, and 5% in South and Central
America. Characteristics of the study population are shown
in Table S1. Women’s mean age varied between the groups
from 31 to 33 years, mean age on immigration from 22 to
27 years, and mean length of stay in Norway from 6 to
9 years. Compared with Norwegian women, fewer immi-
grants were working and/or in education, had a Norwegian
spouse, and had a Norwegian GP, and more immigrant
women were married and had given birth. The proportion
of immigrant women having a female GP varied from 37
to 47%, compared with 40% of the native women.
Table 1 shows user rates of hormonal contraceptives
according to women’s area of origin and age. Oral hor-
monal contraceptives were dispensed to four times as many
women than were non-oral formulations. Relatively more
native women (38%) were dispensed hormonal contracep-
tives than were all groups of immigrants; user rates among
immigrants varied between 15 and 24%. Use of oral hor-
monal contraceptives decreased with increasing women’s
age. Differences in using oral and non-oral hormonal con-
traceptives between the native women and the immigrant
groups were most prominent among women aged 16–
25 years. Non-oral contraceptives comprised a larger share
of overall use of contraceptives for women from Africa and
Asia than for native women and all other immigrant
groups. Hormonal IUDs were most commonly used by
older women.
Figure 1 shows the association between length of stay in
Norway and use of hormonal contraceptives for the two
aggregated immigrant groups as compared with the Norwe-
gian women (reference, OR = 1), by three age groups. The
likelihood of using hormonal contraceptives increased dur-
ing the first 5 years after immigration. The differences in
use of contraceptives between immigrants and Norwegians
were smallest in the oldest age group.
Table 2 shows the association of use of any hormonal
contraceptive with women’s world region of origin.
Women from Africa, Asia and Eastern Europe were less
likely to receive any hormonal contraceptive than were
native women and all other groups of immigrants. Because
of interactions, the adjusted ORs for the aggregated groups
are shown in Figure 2.
Figure 2 shows the association of use of some hormonal
contraceptive with age for two aggregated groups of immi-
grants; Figure 2A is restricted to women in work/education,
Figure 2B to those not being working and/or in education.
Results presented in both figures are adjusted for having a
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Figure 1. Association of contraceptive use with length of stay, for
immigrant women from (A) Nordic countries, Western countries, South
and Central America, and (B) Asia, Africa, Eastern Europe. Odds ratio
(OR) for three age groups.
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female GP and having a Norwegian GP. The impact of
adjustment varied between immigrant groups, but the con-
fidence interval only overlapped with native women among
the oldest women in the aggregated group with highest use
of contraceptives who were working/in education.
Table 3 shows the adjusted association of using any hor-
monal contraceptive with women’s characteristics, for
native women and for two aggregated immigrant groups
with relatively high and low use of hormonal contracep-
tives, respectively. In all three groups, being in work and/or
education was a predictor of using oral contraceptives, with
greatest impact on those immigrants with relatively high
use of hormonal contraceptives. For immigrants, having
lived in Norway for 5 years or more and a relatively young
age of immigration, predicted use of hormonal contracep-
tives. In all groups, having a female GP increased the likeli-
hood of using any contraceptive. Being married and giving
birth were both associated with lower use of contraceptives
in native women, but increased use in those immigrant
groups with relatively low use. Adjusted data for immi-
grants according to each world area of origin are presented
in Table S2.
Discussion
Main findings
Our results show that a smaller share of immigrants than
native women in Norway used hormonal contraceptives.
Table 1. Use of hormonal contraceptives in Norway in 2008. Distribution by women’s area of origin and age group
Age group
(years)
Hormonal
contraceptives
Norway Nordic
countries
Western
countries*
Eastern
Europe
Asia** Africa South and
Central
America
All women, n 762 993 14 137 12 550 32 298 50 120 15 088 5887
Oral, % 31.6 19.6 15.9 11.8 11.7 11.1 19.7
IUD and implants, % 2.8 2.3 1.5 1.2 1.7 1.6 1.8
Other, %*** 4.7 3.0 2.1 2.2 2.5 3.1 4.1
Any, % 37.7 24.1 18.9 14.7 15.2 15.1 24.3
16–25, n 238 404 3144 2128 8329 11 264 4061 1104
Oral, % 57.3 27.1 20.4 19.4 16.5 12.5 31.1
IUD and implants, % 1.1 0.9 0.4 0.7 0.9 1 1.4
Other, % 6.1 3.5 1.9 3.1 2.8 3.6 6.0
Any, % 62.1 30.2 22.2 22.4 19.4 16.2 36.1
26–35, n 236 019 5573 5054 14 543 21 591 6517 2769
Oral, % 32.1 24.7 20.7 12 12.9 13.2 22.1
IUD and implants, % 3.4 2.1 1.6 1.2 2.1 1.9 1.9
Other, % 5.4 3.9 2.8 2.2 2.9 3.7 4.6
Any, % 39.2 29.8 24.3 14.9 16.9 18.0 27.3
36–45, n 288 570 5420 5368 9426 17 265 4510 2014
Oral, % 10.0 10.1 9.6 4.9 7.1 6.8 10.2
IUD and implants, % 3.8 3.3 1.7 1.5 1.8 1.6 1.9
Other, % 3.0 1.9 1.5 1.5 1.9 1.9 2.4
Any, % 16.2 14.7 12.5 7.5 10.4 9.8 13.9
The rows with different contraceptives do not add up to ‘Any’ because women may have used several types.
*Western Europe, North America, Australia and New Zealand.
**Asia including Turkey, Oceania except Australia and New Zealand.
***Vaginal rings, injections and patches.
Table 2. Binary logistic regression. Crude OR and 95% confidence
interval (CI) of use of hormonal contraceptives with women’s world
region of origin
World region of origin Crude OR (95% CI)
Norway (reference) 1
Nordic countries 0.53 (0.51–0.55)
Western countries* 0.39 (0.37–0.40)
Eastern Europe 0.29 (0.28–0.29)
Asia** 0.30 (0.29–0.31)
Africa 0.29 (0.28–0.31)
South and Central America 0.53 (0.50–0.57)
*Including Western Europe, North America, Australia and New
Zealand.
**Asia including Turkey, Oceania except Australia and New Zealand.
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There was considerable variation between the immigrant
groups, but all groups had lower user rates than natives.
The use of hormonal contraceptives decreased with increas-
ing age, and group differences were largest in the youngest
age group 16–25 years. Being in work and/or education,
longer length of stay, and young age on immigration to
Norway, were predictors of using hormonal contraceptives
for immigrants.
Strengths and limitations
The national registries provided us a unique opportunity to
link complete data on hormonal contraceptives purchased
by a national female population with women’s immigrant
status. The linked data enabled us to study drug use
according to immigrants’ area of origin, adjusted for
socio-economic and other variables. The nationwide study
design eliminated selection and information bias.
However, some limitations should be considered. First,
the Norwegian Prescription Database contains information
on prescription drugs that were purchased, not on actual
drug use. Thus, collected supplies served as surrogate mar-
ker for contraceptive use in the current study. This method
does not account for compliance but is recognized in epi-
demiological studies.21 Prior studies have revealed lower
compliance among immigrants.12 If this applies to the
immigrants in our study, the differences we found should
be considered conservative estimates. Secondly, we lack
information on other forms of contraception such as cop-
per IUDs, sterilisation, vasectomy and condoms. Although
this study showed that immigrant women used fewer hor-
monal contraceptives than natives did, many of them
might be using ‘effective’ non-hormonal contraception
methods. Copper IUDs are still used, though not registered
in the Norwegian Prescription Database. However, based
on figures from drug wholesalers, copper IUDs only consti-
tuted 27% of all IUDs sold in Norway in 2008,22 and our
findings are consistent with a recent study that included
information on IUDs.13 Thirdly, both IUDs and implants
are typically used for several consecutive years and overall
use is therefore underestimated in this study, but this
underestimation would apply for both natives and immi-
grants. Lastly, our definition of a contraceptive user
included all women who collected at least one supply of
hormonal contraceptives during 2008, regardless of the
number of drug supplies. The reason for this choice was
that we considered purchase of contraceptives a surrogate
marker for women knowing how to get access to contra-
ceptives. Although this might overestimate the number of
users, this would apply to all groups and hence not inter-
fere with comparisons between groups.
Interpretation
To the best of our knowledge, prior studies have not com-
pared user rates of contraceptives between immigrant and
native women at the population level, or among groups
based on country of origin. One study in France compared
self-reported user rates of contraceptives between immi-
grants and natives,13 and several studies have compared
user rates of contraceptives only among women undergoing
induced abortion.10,12 Our results showing lower contra-
ceptive use among immigrants are consistent with the find-
ings from these studies.10,12,13 The association between
higher socio-economic status and use of contraceptives in a
general population is well established.1,4 but the only study
to date examining predictors of contraceptive use among
immigrants found that the impact of socioeconomic status
was different for immigrants and natives.13 Our study con-
firms that being in work and/or education is an important
predictor among all groups, especially in the aggregated
immigrant group with high use of contraceptives. Adjusting
for being in work and/or education, however, did not in
itself explain the main differences between immigrants and
natives.
Culture and religion influence sexuality and use of con-
traception in some immigrant groups.5 Because the need
for contraception may vary between women from different
cultures, it is adequate to question the use of native women
as the reference group. However, high prevalence rates of
induced abortion among immigrants and ethnic minorities
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Figure 2. Association of contraceptive use with age, for women (A) in
work/education and (B) not in work/education. Odds ratio (OR) for
three groups.
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in Scandinavia and the USA,4,8–10 and adaptation to their
new country of residence regarding sexuality and the health
care system,7 suggest there are unmet needs in those groups
with lower use of contraception.
All hormonal contraceptives dispensed in Norwegian
pharmacies are included in our study. Some immigrant
women, however, may have brought contraceptives with
them upon immigration, and also purchased drugs when
visiting their country of origin.23 This may apply to some
women from European countries and partly explain the
increase in use of contraceptives during the first 5 years in
Norway. However, not all women have the opportunity to
travel to their country of origin, and use of hormonal con-
traceptives remains lowest among women from areas where
contraceptives are less accessible than in Norway. As a pro-
portion of overall hormonal contraception, non-oral meth-
ods were more widely used in the youngest immigrants
from Asia, Africa, and South and Central America com-
pared with Norwegian women and other immigrant
groups. These differences are in accordance with patterns
of use among ethnic minorities in the USA4 and should be
given further consideration as these groups might express
cultural preferences that the prescriber should be aware of
when giving advice on family planning.
We expected women who had delivered in 2008 or the
first part of 2009 to have lower use of hormonal contracep-
tives in 2008. Although this was the case for Norwegians
and immigrants with high use of contraception, among
immigrants with relatively low use of hormonal contracep-
tives, delivery was associated with higher use of contracep-
tives. Although the nature of this study does not allow for
causal explanations, one possible theory is related to the
organisation of the Norwegian health care system. In Nor-
way there is a free control visit with the GP 6 weeks after
delivery, and the need for contraception is one of the top-
ics that should be discussed with the woman at that time.
It is possible that immigrants that usually do not have con-
tact with the health system may use this opportunity to get
prescriptions for contraceptives.
Provider-related factors can influence the use of drugs.
Immigrant women prefer to have an immigrant GP,24 but
it has not previously been studied whether this choice has
an impact on use of contraceptives. In our study, having a
Norwegian GP slightly increased the likelihood of using
hormonal contraceptives among native women and among
those immigrants with relatively low use of contraceptives,
while having a female GP had a larger impact on all
groups. This last finding is supported by a previous
study.25
Conclusion
This nationwide registry-based study confirms that fewer
immigrant women use hormonal contraception compared
Table 3. Association of use of hormonal contraceptives with women’s characteristics, for Norwegian women and two immigrant groups. Odds
ratio (OR) and 95% confidence interval
Norway Immigrants with high
contraceptive use*
Immigrants with low
contraceptive use**
Crude OR
(95% CI)
Adjusted
OR***
(95% CI)
Crude OR
(95% CI)
Adjusted
OR***
(95% CI)
Crude OR
(95% CI)
Adjusted
OR***
(95% CI)
In work/education 1.66 (1.64–1.69) 1.42 (1.40–1.45) 2.17 (2.01–2.34) 1.87 (1.72–2.04) 1.50 (1.45–1.57) 1.24 (1.19–1.29)
Length of stay in Norway
≥5 years
– – 1.29 (1.22–1.36) 1.21 (1.11–1.31) 1.57 (1.51–1.63) 1.29 (1.23–1.36)
Age at immigration (ref = 31–45 years)
0–15 years – – 4.55 (4.12–5.02) 1.22 (1.05–1.42) 3.73 (3.50–3.98) 1.38 (1.25–1.53)
16–30 years – – 2.07 (1.91–2.24) 1.07 (0.97–1.19) 1.95 (1.84–2.07) 1.23 (1.15–1.33)
Female general practitioner 1.08 (1.07–1.09) 1.12 (1.11–1.13) 1.12 (1.06–1.19) 1.15 (1.08–1.23) 1.20 (1.15–1.24) 1.16 (1.12–1.21)
Norwegian general
practitioner
1.02 (1.01–1.03) 1.02 (1.01–1.04) 0.95 (0.89–1.01) 0.97 (0.91–1.04) 1.09 (1.05–1.13) 1.08 (1.04–1.12)
Delivery between January
2008 and June 2009
0.84 (0.83–0.86) 0.82 (0.80–0.83) 1.08 (1.00–1.16) 0.93 (0.85–1.01) 1.18 (1.13–1.24) 1.12 (1.06–1.18)
Married 0.30 (0.30–0.31) 0.66 (0.65–0.66) 0.67 (0.64–0.71) 0.91 (0.85–0.97) 0.82 (0.79–0.85) 1.13 (1.08–1.18)
Age, years 0.90 (0.90–0.90) 0.91 (0.91–0.91) 0.95 (0.94–0.95) 0.93 (0.92–0.93) 0.96 (0.96–0.96) 0.95 (0.95–0.96)
*Immigrants from Nordic Countries and Western Countries, South and Central America.
**Immigrants from Eastern Europe, Asia, and Africa.
***Adjusted for all other independent variables in the model.
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with native women, and these observations are consistent
after adjustment for socio-economic and provider-related
factors. However, our study was unable to ascertain whether
these differences were related to factors such as desires for
fertility or preferences for non-hormonal contraception in
recently arrived and established immigrants. Furthermore,
the extent to which immigrant contraceptive needs are met
is unclear. Further work including qualitative research is
necessary to examine the cultural, economic, healthcare
system or provider-related reasons why immigrants use
fewer hormonal contraceptives compared with native
women. In addition, the association between choice of con-
traceptive method and culture or country of origin should
be investigated. Finally, method switching and discontinua-
tion should be targeted in longitudinal studies.
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